Business
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, intends to execute a new share buyback program with a total volume of around EUR 1 billion. The program shall be executed in tranches over a period of 12 months from its start.
About this update from Fresenius Medical Care Ag
[{"type":"list","items":[{"val":[{"type":"text","content":"Total volume of the share buyback is around EUR 1 billion over 12 months","length":77,"tagName":"p"}]},{"val":[{"type":"text","content":"Share buyback expected to begin in the near future","length":50,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":127,"olType":false},{"type":"text","content":"BAD HOMBURG, Germany, May 26, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, intends to execute a new share buyback program with a total volume of around EUR 1 billion. The program shall be executed in tranches over a period of 12 months from its start.","length":352,"tagName":"p"},{"type":"image","alt":"Fresenius Medical Care (PRNewsfoto/Fresenius Medical Care North Am)","displaySize":"","headline":null,"caption":"Fresenius Medical Care (PRNewsfoto/Fresenius Medical Care North Am)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":86,"url":"https://media.zenfs.com/en/prnewswire.com/db51fddc83624ba4f412f9c93991ee18"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cA.S3e4rWTO7VZMzptDkww--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1Mg--/https://media.zenfs.com/en/prnewswire.com/db51fddc83624ba4f412f9c93991ee18","width":400,"height":86},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/2hPZS.POkO3p7bdanA5_Aw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTEzOA--/https://media.zenfs.com/en/prnewswire.com/db51fddc83624ba4f412f9c93991ee18","width":400,"height":86}},"href":"https://mma.prnewswire.com/media/2987719/FMC_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The share buyback program is based on the authorization to purchase and use treasury shares granted by the Company's Annual General Meeting on May 21, 2026. It is expected to begin in the near future and only a few weeks after the previous share buyback program was successfully completed on April 30, 2026. As part of FME's capital allocation framework, regular share buyback programs complement dividend payments and reflect the Company's continued focus on disciplined capital allocation and value creation.","length":522,"tagName":"p"},{"type":"text","content":"Helen Giza, CEO and Chair of the Management Board of Fresenius Medical Care AG, said, "The new share buyback progr...